Flecainide Acetate
Brand names: Flecainide Acetate
At a glance
- Medicare prescriptions, 2024
- 1,026,477
- Medicare drug cost
- $42.5M
- Average cost per prescription
- $41.38
- Clinicians who prescribed it
- 22,077
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
In patients without structural heart disease, flecainide is indicated for the prevention of - paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms - paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms.
From the FDA-approved prescribing information (label dated June 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Cardiology 35.7%
- Cardiac Electrophysiology 23.7%
- Nurse Practitioners 15.3%
- Interventional Cardiology 9.8%
- Physician Assistants 5.9%
- Internal Medicine 4.7%
- Family Medicine 3.6%
- Geriatric Medicine 0.4%
- General Practice 0.2%
- Nuclear Medicine 0.2%
- Heart Failure & Transplant Cardiology 0.2%
- Hospitalist 0.1%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 29% from 2019 to 2024.
Biggest change by state since 2019
- Arkansas +63%
- Maryland +54%
- West Virginia +52%
- Indiana +51%
- New Jersey +47%
- Colorado (smallest change) +10%
- California (smallest change) +16%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 4 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Amneal Pharmaceuticals of New York LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 50 mg | white round tablet, 7 mm | AN 641 |
| 100 mg | white round tablet, 9 mm, scored to split in 2 | AN 642 |
| 150 mg | white oval tablet, 13 mm, scored to split in 2 | AN 643 |
Bryant Ranch Prepack
| Strength | Looks like | Imprint |
|---|---|---|
| 100 mg | white round tablet, 9 mm, scored to split in 2 | BPL026 |
Epic Pharma, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 50 mg | white round tablet, 6 mm | YH 777 |
| 100 mg | white round tablet, 9 mm, scored to split in 2 | YH 717 |
| 150 mg | white capsule, 14 mm, scored to split in 2 | YH 711 |
Pd-Rx Pharmaceuticals, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 50 mg | white round tablet, 7 mm | BPL025 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.